San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

New Innovation Space Means Business When Selecting Startups

The Qualcomm Institute is launching a new innovation space at the University of California, San Diego with the capacity to house 15 to 20 seed-stage startups.

Tease photo

Isis Brings Big Pharma on Board for Its Antithrombotic Drug

BIOTECH: Deal With Bayer May Be Worth Up to $375 Million

Isis Pharmaceuticals has landed a megadeal with aspirin-maker Bayer AG to move a potential blockbuster drug from the lab to the market.

Tease photo


BIOTECH: Bioprinter Aims to Give L’Oreal Tissue for Product Testing

Organovo has landed a research partnership with beauty conglomerate L’Oreal to create 3-D bioprinted human skin to test cosmetics.

Tease photo

Sorrento Therapeutics Sells Cancer Drug and Subsidiary

In a deal potentially worth up to $1.3 billion, San Diego’s Sorrento Therapeutics has sold the rights to its proposed cancer treatment Cynviloq, as well as the wholly owned subsidiary that was developing the drug, to Illinois-based NantPharma.

Celladon to Cut Staff After Therapy Fails Key Trial

San Diego drug developer Celladon Corp. said it is laying off half of its staff to cut costs after its lead gene therapy to treat heart failure failed a key trial last month.

Sanford-Burnham, Eli Lilly Announce Collaboration

San Diego’s research community has attracted a new Big Pharma partner. Sanford-Burnham Medical Research Institute will collaborate with Eli Lilly and Company to develop immunological therapies, the companies announced Thursday.

Scripps, Sharp to Join Health Information Exchange

Scripps Health and Sharp Healthcare are joining San Diego Health Connect, a substantial boost for the region’s health information exchange that soon will give clinicians access to medical data covering 2.7 million county residents.

ResMed Says Phase 3 Clinical Trial Falls Short

Medical device maker ResMed announced that a major clinical trial that sought to show its sleep therapy products protected heart failure patients actually slightly increased the risk of death.

Orexigen, Takeda Halt Study of Obesity Drug

San Diego’s Orexigen Therapeutics Inc. and its marketing partner Takeda Pharmaceutical Co. Ltd. on Tuesday abruptly terminated a study into how Orexigen’s Contrave obesity drug might affect the cardiovascular system.

Tease photo

Ligand Pharmaceuticals Acquires a Portfolio From Swiss Firm for $4 Million

Ligand Pharmaceuticals Inc. has spent $4 million to acquire a portfolio of more than 15 biologic development programs from Swiss biotech firm Selexis SA, which could provide future milestone and royalty payments.

Cidara Therapeutics Receives Fast-Track Status for Drug Candidate

San Diego-based Cidara Therapeutics Inc. has received fast-track designation from the U.S. Food and Drug Administration for its leading drug candidate for fungal infections.

Vical Reports Q1 Net Loss of $3.8M

San Diego-based Vical Inc. reported a net loss of $3.8 million for the first quarter of 2015, compared with a net loss of $3.5 million in the same quarter the previous year.

Acadia Pharmaceuticals Reports Q1 Net Loss of $40.4M

San Diego-based Acadia Pharmaceuticals Inc. reported a net loss of $40.4 million in the first quarter of 2015, more than double the net loss of $17.8 million during the same quarter last year.

UCSD Health System to Partner with El Centro

HEALTH: Hospital In Rancho Mirage Is Also in Talks

UC San Diego Health System and the City of El Centro are entering into an agreement to expand health care services to Imperial Valley, the university announced.

Tri-City Buying An Advanced CT Scanner

BIOTECH: Device Can Rapidly Rule Out Cardiac Disease

The Tri-City Healthcare District Board of Directors has approved the purchase and installation of one of the most advanced computed tomography (CT) scanners on the market, enabling its radiologists to make quick and accurate diagnoses for patients.